Bullous pemphigoid induced by ipilimumab in a patient with metastatic malignant melanoma after unsuccessful treatment with nivolumab

J Dermatol. 2018 Jan;45(1):e21-e22. doi: 10.1111/1346-8138.14043. Epub 2017 Sep 25.

Authors

Yutaka Kuwatsuka¹, Akira Iwanaga¹, Sayaka Kuwatsuka¹, Yumi Okubo^{1

2}, Naoya Murayama¹, Norito Ishii³, Takashi Hashimoto⁴, Atsushi Utani¹

Affiliations

¹ Department of Dermatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
² Research and Clinical Center for Yusho and Dioxin, Kyushu University Hospital, Fukuoka, Japan.
³ Department of Dermatology, Kurume University School of Medicine, Kurume, Japan.
⁴ Kurume University Institute of Cutaneous Cell Biology, Kurume, Japan.

PMID: 28944534
DOI: 10.1111/1346-8138.14043

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Antineoplastic Agents, Immunological / adverse effects*
Antineoplastic Combined Chemotherapy Protocols / adverse effects*
Drug Resistance, Neoplasm
Humans
Ipilimumab / adverse effects*
Lower Extremity
Male
Melanoma / drug therapy
Melanoma / pathology
Nivolumab / adverse effects*
Pemphigoid, Bullous / chemically induced*
Pemphigoid, Bullous / immunology
Pemphigoid, Bullous / pathology
Skin / drug effects
Skin / pathology
Skin Neoplasms / drug therapy
Skin Neoplasms / pathology
Treatment Failure

Substances

Antineoplastic Agents, Immunological
Ipilimumab
Nivolumab